ENTITY
Molecular Partners AG

Molecular Partners AG (MOLN SW)

Health CareSwitzerland
Molecular Partners AG develops and markets biopharmaceutical products. The Company develops designed ankyrin repeat protein platform therapies used in ophthalmology, oncology, inflammation, and other therapeutic treatments. Molecular Partners serves healthcare professionals and patients internationally.
more
Company Event12 Mar 2026 14:00 • Upcoming
Add To Calendar
Company Event12 Nov 2025 23:00 • Latest
Company Event31 Oct 2025 04:00 • Upcoming
Add To Calendar
Company Event25 Aug 2025 15:00 • Upcoming
Add To Calendar
Company Event28 May 2025 22:00
x